Combination Therapy of BRAF Inhibitors for Advanced Melanoma with BRAF V600 Mutation: A Systematic Review and Meta-Analysis.

CONCLUSIONS: Combination therapy with BRAF inhibitors and MEK inhibitors significantly improved OS, PFS, and ORR in patients with advanced melanoma with BRAF mutation.
PMID: 28504036 [PubMed - as supplied by publisher]

Source: Journal of Dermatological Treatment - May 17, 2017 Category: Dermatology Tags: J Dermatolog Treat Source Type: research